Related references
Note: Only part of the references are listed.Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial
Andrew W. Horne et al.
LANCET (2023)
Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies
Amy Goh et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2020)
Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy
Jing Zhang et al.
BMC PREGNANCY AND CHILDBIRTH (2020)
Early prediction of the success of methotrexate treatment success by 24-hour pretreatment increment in HCG and day 1-4 change in HCG
Gabriel Levin et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2019)
Predicting success of methotrexate treatment by pretreatment HCG level and 24-hour HCG increment
Gabriel Levin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Trends in serum human chorionic gonadotropin levels 0-4days after methotrexate administration for predicting tubal ectopic pregnancy treatment success
Lo Wong et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Tubal Ectopic Pregnancy
Kurt T. Barnhart et al.
OBSTETRICS AND GYNECOLOGY (2018)
Significant increase in serum hCG levels following methotrexate therapy is associated with lower treatment success rates in ectopic pregnancy patients
Roy Mashiach et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)
A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol
James May et al.
TRIALS (2018)
Diagnosis and Management of Ectopic Pregnancy
[Anonymous]
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2016)
Post-traumatic stress, anxiety and depression following miscarriage or ectopic pregnancy: a prospective cohort study
Jessica Farren et al.
BMJ OPEN (2016)
Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy
Emin Ustunyurt et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2013)
Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison
N. M. van Mello et al.
HUMAN REPRODUCTION (2013)
Efficacy and safety of a clinical protocol for expectant management of selected women diagnosed with a tubal ectopic pregnancy
D. Mavrelos et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2013)
Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study
Monika Skubisz et al.
BMC PREGNANCY AND CHILDBIRTH (2013)
Ectopic Pregnancy: History, Incidence, Epidemiology, and Risk Factors
Laura L. Marion et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2012)
Has increased clinical experience with methotrexate reduced the direct costs of medical management of ectopic pregnancy compared to surgery?
Daniel T. Westaby et al.
BMC PREGNANCY AND CHILDBIRTH (2012)
Decline in ßhCG levels between days 0 and 4 after a single dose of methotrexate for ectopic pregnancy predicts treatment success: a retrospective cohort study
M. M. Skubisz et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2011)
Diagnosis and management of ectopic pregnancy
Davor Jurkovic et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy?
Quyen Nguyen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy
E. Kirk et al.
HUMAN REPRODUCTION (2007)
ROCR: visualizing classifier performance in R
T Sing et al.
BIOINFORMATICS (2005)